Premium Service

We offer a premium marketplace service on the Seeking Alpha platform. The service is geared toward long-term investing and subscribers get access to our firm's exclusive research reports. Additionally, subscribers of the service get one-on-one access to our President and Chief Investment Officer, William J. Block, CPA. Read more about the service here

Blog Posts (free content)

Recent Posts

Archive

Charles River Laboratories: Strong Results But Not Out Of The Woods Just Yet

Summary: - Charles River reported Q2 2020 results that beat the top and bottom line estimates. However, the company's research business contended with strong headwinds again this quarter. - The COVID-19-related headwinds will likely continue to impact Charles River's results in the near-term, but the company is still well-positioned for the future (the revised 2020 guidance proves it). - This small-cap drug discovery and early-stage development company has a great long-term story to tell. Additionally, I believe that the company's investment thesis keeps getting stronger. Charles River Laboratories' ($CRL) stock has performed well so far in 2020, as CRL shares are outperforming the broader m

 

©2020 W.G. INVESTMENT RESEARCH LLC.